APO Research
Talk to an analyst

APO RESEARCH · REPORT

Home Insulin Delivery (Dosing) Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Home Insulin Delivery (Dosing) Devices Market Outlook and Growth Opportunities 2026

4 July 2026212 pages

Choose your research edition.

Industry ResearchHome Insulin Delivery (Dosing) Devices Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Home Insulin Delivery (Dosing) Devices Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Home Insulin Delivery (Dosing) Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Home Insulin Delivery (Dosing) Devices Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Home Insulin Delivery (Dosing) Devices Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Home Insulin Delivery (Dosing) Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Home Insulin Delivery (Dosing) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Home Insulin Delivery (Dosing) Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Home Insulin Delivery (Dosing) Devices market include Medtronic, Ypsomed Holding, Wockhardt, West Pharma, Valeritas, Tandem Diabetes Care, SOOIL, Sanofi and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Home Insulin Delivery (Dosing) Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Home Insulin Delivery (Dosing) Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Home Insulin Delivery (Dosing) Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Insulin Delivery (Dosing) Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Home Insulin Delivery (Dosing) Devices Segment by Company

Medtronic

Ypsomed Holding

Wockhardt

West Pharma

Valeritas

Tandem Diabetes Care

SOOIL

Sanofi

Roche Holding AG

Owen Mumford

Novo Nordisk

MannKind

Julphar

Insulet Corporation

Eli Lilly and Company

Debiotech

Dance Biopharm

Copernicus

Biocon

Beta Bionics

BD

B. Braun

Home Insulin Delivery (Dosing) Devices Segment by Type

Insulin Pumps

Insulin Pens

Insulin Syringes

Others

Home Insulin Delivery (Dosing) Devices Segment by Application

Online Pharmacy

Retail Pharmacy

Hospitals Pharmacy

Home Insulin Delivery (Dosing) Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Home Insulin Delivery (Dosing) Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Home Insulin Delivery (Dosing) Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Home Insulin Delivery (Dosing) Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Home Insulin Delivery (Dosing) Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Insulin Delivery (Dosing) Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Insulin Delivery (Dosing) Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Insulin Delivery (Dosing) Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Home Insulin Delivery (Dosing) Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Home Insulin Delivery (Dosing) Devices industry.

Chapter 3: Detailed analysis of Home Insulin Delivery (Dosing) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Home Insulin Delivery (Dosing) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Home Insulin Delivery (Dosing) Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Home Insulin Delivery (Dosing) Devices Industry Trends Table 2. Home Insulin Delivery (Dosing) Devices Industry Drivers Table 3. Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges Table 4. Home Insulin Delivery (Dosing) Devices Industry Restraints Table 5. Global Home Insulin Delivery (Dosing) Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Company (2021-2026) Table 7. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Company (2021-2026) Table 9. Global Home Insulin Delivery (Dosing) Devices Average Price (USD/unit) of Company (2021-2026) Table 10. Global Home Insulin Delivery (Dosing) Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Home Insulin Delivery (Dosing) Devices Key Company Manufacturing Base & Headquarters Table 12. Global Home Insulin Delivery (Dosing) Devices Company, Product Type & Application Table 13. Global Home Insulin Delivery (Dosing) Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Home Insulin Delivery (Dosing) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Insulin Pumps Table 18. Significant Companies of Insulin Pens Table 19. Significant Companies of Insulin Syringes Table 20. Significant Companies of Others Table 21. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Type (2021-2026) & (k units) Table 23. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Type (2027-2032) & (k units) Table 24. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Type (2021-2026) Table 25. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Type (2027-2032) Table 26. Global Home Insulin Delivery (Dosing) Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Home Insulin Delivery (Dosing) Devices Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Home Insulin Delivery (Dosing) Devices Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Type (2021-2026) Table 30. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Online Pharmacy Table 32. Significant Companies of Retail Pharmacy Table 33. Significant Companies of Hospitals Pharmacy Table 34. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Application (2021-2026) & (k units) Table 36. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Application (2027-2032) & (k units) Table 37. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Application (2021-2026) Table 38. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Application (2027-2032) Table 39. Global Home Insulin Delivery (Dosing) Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Home Insulin Delivery (Dosing) Devices Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Home Insulin Delivery (Dosing) Devices Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Application (2021-2026) Table 43. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Application (2027-2032) Table 44. Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2026) & (k units) Table 46. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2021-2026) Table 47. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2027-2032) & (k units) Table 48. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2027-2032) Table 49. Global Home Insulin Delivery (Dosing) Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Home Insulin Delivery (Dosing) Devices Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Region (2021-2026) Table 52. Global Home Insulin Delivery (Dosing) Devices Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Region (2027-2032) Table 54. Global Home Insulin Delivery (Dosing) Devices Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Home Insulin Delivery (Dosing) Devices Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Home Insulin Delivery (Dosing) Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Home Insulin Delivery (Dosing) Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026) & (k units) Table 59. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2021-2026) Table 60. Global Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032) & (k units) Table 61. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2027-2032) Table 62. Global Home Insulin Delivery (Dosing) Devices Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Home Insulin Delivery (Dosing) Devices Sales Value Market Share by Country (2021-2026) Table 64. Global Home Insulin Delivery (Dosing) Devices Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Home Insulin Delivery (Dosing) Devices Sales Value Market Share by Country (2027-2032) Table 66. Medtronic Company Information Table 67. Medtronic Business Overview Table 68. Medtronic Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio Table 70. Medtronic Recent Development Table 71. Ypsomed Holding Company Information Table 72. Ypsomed Holding Business Overview Table 73. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio Table 75. Ypsomed Holding Recent Development Table 76. Wockhardt Company Information Table 77. Wockhardt Business Overview Table 78. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio Table 80. Wockhardt Recent Development Table 81. West Pharma Company Information Table 82. West Pharma Business Overview Table 83. West Pharma Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio Table 85. West Pharma Recent Development Table 86. Valeritas Company Information Table 87. Valeritas Business Overview Table 88. Valeritas Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio Table 90. Valeritas Recent Development Table 91. Tandem Diabetes Care Company Information Table 92. Tandem Diabetes Care Business Overview Table 93. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio Table 95. Tandem Diabetes Care Recent Development Table 96. SOOIL Company Information Table 97. SOOIL Business Overview Table 98. SOOIL Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio Table 100. SOOIL Recent Development Table 101. Sanofi Company Information Table 102. Sanofi Business Overview Table 103. Sanofi Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio Table 105. Sanofi Recent Development Table 106. Roche Holding AG Company Information Table 107. Roche Holding AG Business Overview Table 108. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio Table 110. Roche Holding AG Recent Development Table 111. Owen Mumford Company Information Table 112. Owen Mumford Business Overview Table 113. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio Table 115. Owen Mumford Recent Development Table 116. Novo Nordisk Company Information Table 117. Novo Nordisk Business Overview Table 118. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio Table 120. Novo Nordisk Recent Development Table 121. MannKind Company Information Table 122. MannKind Business Overview Table 123. MannKind Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio Table 125. MannKind Recent Development Table 126. Julphar Company Information Table 127. Julphar Business Overview Table 128. Julphar Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio Table 130. Julphar Recent Development Table 131. Insulet Corporation Company Information Table 132. Insulet Corporation Business Overview Table 133. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio Table 135. Insulet Corporation Recent Development Table 136. Eli Lilly and Company Company Information Table 137. Eli Lilly and Company Business Overview Table 138. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio Table 140. Eli Lilly and Company Recent Development Table 141. Debiotech Company Information Table 142. Debiotech Business Overview Table 143. Debiotech Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio Table 145. Debiotech Recent Development Table 146. Dance Biopharm Company Information Table 147. Dance Biopharm Business Overview Table 148. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio Table 150. Dance Biopharm Recent Development Table 151. Copernicus Company Information Table 152. Copernicus Business Overview Table 153. Copernicus Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio Table 155. Copernicus Recent Development Table 156. Biocon Company Information Table 157. Biocon Business Overview Table 158. Biocon Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio Table 160. Biocon Recent Development Table 161. Beta Bionics Company Information Table 162. Beta Bionics Business Overview Table 163. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio Table 165. Beta Bionics Recent Development Table 166. BD Company Information Table 167. BD Business Overview Table 168. BD Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. BD Home Insulin Delivery (Dosing) Devices Product Portfolio Table 170. BD Recent Development Table 171. B. Braun Company Information Table 172. B. Braun Business Overview Table 173. B. Braun Home Insulin Delivery (Dosing) Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio Table 175. B. Braun Recent Development Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Home Insulin Delivery (Dosing) Devices Distributors List Table 179. Home Insulin Delivery (Dosing) Devices Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Home Insulin Delivery (Dosing) Devices Product Image Figure 2. Global Home Insulin Delivery (Dosing) Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Home Insulin Delivery (Dosing) Devices Sales (2021-2032) & (k units) Figure 5. Global Home Insulin Delivery (Dosing) Devices Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Home Insulin Delivery (Dosing) Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Insulin Pumps Image Figure 10. Insulin Pens Image Figure 11. Insulin Syringes Image Figure 12. Others Image Figure 13. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Type (2021-2032) Figure 16. Global Home Insulin Delivery (Dosing) Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Home Insulin Delivery (Dosing) Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Type (2021-2032) Figure 19. Online Pharmacy Image Figure 20. Retail Pharmacy Image Figure 21. Hospitals Pharmacy Image Figure 22. Global Home Insulin Delivery (Dosing) Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Application (2021-2032) Figure 25. Global Home Insulin Delivery (Dosing) Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Home Insulin Delivery (Dosing) Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Application (2021-2032) Figure 28. Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Home Insulin Delivery (Dosing) Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032) & (US$ Million) Figure 33. North America Home Insulin Delivery (Dosing) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Home Insulin Delivery (Dosing) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032) & (US$ Million) Figure 39. South America Home Insulin Delivery (Dosing) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Home Insulin Delivery (Dosing) Devices Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Home Insulin Delivery (Dosing) Devices Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Others
Applications
  • Online Pharmacy
  • Retail Pharmacy
  • Hospitals Pharmacy
Companies covered
  • Medtronic
  • Ypsomed Holding
  • Wockhardt
  • West Pharma
  • Valeritas
  • Tandem Diabetes Care
  • SOOIL
  • Sanofi
  • Roche Holding AG
  • Owen Mumford
  • Novo Nordisk
  • MannKind
  • Julphar
  • Insulet Corporation
  • Eli Lilly and Company
  • Debiotech
  • Dance Biopharm
  • Copernicus
  • Biocon
  • Beta Bionics
  • BD
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032)
  4. 1.2.2 Global Home Insulin Delivery (Dosing) Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Home Insulin Delivery (Dosing) Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Home Insulin Delivery (Dosing) Devices Market Dynamics
  1. 2.1 Home Insulin Delivery (Dosing) Devices Industry Trends
  2. 2.2 Home Insulin Delivery (Dosing) Devices Industry Drivers
  3. 2.3 Home Insulin Delivery (Dosing) Devices Industry Opportunities and Challenges
  4. 2.4 Home Insulin Delivery (Dosing) Devices Industry Restraints
3 Home Insulin Delivery (Dosing) Devices Market by Company
  1. 3.1 Global Home Insulin Delivery (Dosing) Devices Company Revenue Ranking in 2025
  2. 3.2 Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2021-2026)
  3. 3.3 Global Home Insulin Delivery (Dosing) Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Home Insulin Delivery (Dosing) Devices Average Price by Company (2021-2026)
  5. 3.5 Global Home Insulin Delivery (Dosing) Devices Company Ranking (2024-2026)
  6. 3.6 Global Home Insulin Delivery (Dosing) Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Home Insulin Delivery (Dosing) Devices Company Product Type and Application
  8. 3.8 Global Home Insulin Delivery (Dosing) Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Home Insulin Delivery (Dosing) Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Home Insulin Delivery (Dosing) Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Home Insulin Delivery (Dosing) Devices Market by Type
  1. 4.1 Home Insulin Delivery (Dosing) Devices Type Introduction
  2. 4.1.1 Insulin Pumps
  3. 4.1.2 Insulin Pens
  4. 4.1.3 Insulin Syringes
  5. 4.1.4 Others
  6. 4.2 Global Home Insulin Delivery (Dosing) Devices Sales Volume by Type
  7. 4.2.1 Global Home Insulin Delivery (Dosing) Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Home Insulin Delivery (Dosing) Devices Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Home Insulin Delivery (Dosing) Devices Sales Value by Type
  11. 4.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Home Insulin Delivery (Dosing) Devices Sales Value by Type (2021-2032)
  13. 4.3.3 Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Type (2021-2032)
5 Home Insulin Delivery (Dosing) Devices Market by Application
  1. 5.1 Home Insulin Delivery (Dosing) Devices Application Introduction
  2. 5.1.1 Online Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospitals Pharmacy
  5. 5.2 Global Home Insulin Delivery (Dosing) Devices Sales Volume by Application
  6. 5.2.1 Global Home Insulin Delivery (Dosing) Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Home Insulin Delivery (Dosing) Devices Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Home Insulin Delivery (Dosing) Devices Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Home Insulin Delivery (Dosing) Devices Sales Value by Application
  10. 5.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Home Insulin Delivery (Dosing) Devices Sales Value by Application (2021-2032)
  12. 5.3.3 Global Home Insulin Delivery (Dosing) Devices Sales Value Share by Application (2021-2032)
6 Home Insulin Delivery (Dosing) Devices Regional Sales and Value Analysis
  1. 6.1 Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Home Insulin Delivery (Dosing) Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Home Insulin Delivery (Dosing) Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Home Insulin Delivery (Dosing) Devices Sales by Region (2027-2032)
  5. 6.3 Global Home Insulin Delivery (Dosing) Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Home Insulin Delivery (Dosing) Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Home Insulin Delivery (Dosing) Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Home Insulin Delivery (Dosing) Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Home Insulin Delivery (Dosing) Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032)
  12. 6.6.2 North America Home Insulin Delivery (Dosing) Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Home Insulin Delivery (Dosing) Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Home Insulin Delivery (Dosing) Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032)
  21. 6.9.2 South America Home Insulin Delivery (Dosing) Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Value Share by Country, 2025 VS 2032
7 Home Insulin Delivery (Dosing) Devices Country-level Sales and Value Analysis
  1. 7.1 Global Home Insulin Delivery (Dosing) Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Home Insulin Delivery (Dosing) Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Home Insulin Delivery (Dosing) Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Home Insulin Delivery (Dosing) Devices Sales by Country (2027-2032)
  6. 7.4 Global Home Insulin Delivery (Dosing) Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Home Insulin Delivery (Dosing) Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Home Insulin Delivery (Dosing) Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Home Insulin Delivery (Dosing) Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Home Insulin Delivery (Dosing) Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Home Insulin Delivery (Dosing) Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Ypsomed Holding
  8. 8.2.1 Ypsomed Holding Company Information
  9. 8.2.2 Ypsomed Holding Business Overview
  10. 8.2.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
  12. 8.2.5 Ypsomed Holding Recent Developments
  13. 8.3 Wockhardt
  14. 8.3.1 Wockhardt Company Information
  15. 8.3.2 Wockhardt Business Overview
  16. 8.3.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
  18. 8.3.5 Wockhardt Recent Developments
  19. 8.4 West Pharma
  20. 8.4.1 West Pharma Company Information
  21. 8.4.2 West Pharma Business Overview
  22. 8.4.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
  24. 8.4.5 West Pharma Recent Developments
  25. 8.5 Valeritas
  26. 8.5.1 Valeritas Company Information
  27. 8.5.2 Valeritas Business Overview
  28. 8.5.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
  30. 8.5.5 Valeritas Recent Developments
  31. 8.6 Tandem Diabetes Care
  32. 8.6.1 Tandem Diabetes Care Company Information
  33. 8.6.2 Tandem Diabetes Care Business Overview
  34. 8.6.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
  36. 8.6.5 Tandem Diabetes Care Recent Developments
  37. 8.7 SOOIL
  38. 8.7.1 SOOIL Company Information
  39. 8.7.2 SOOIL Business Overview
  40. 8.7.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
  42. 8.7.5 SOOIL Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Roche Holding AG
  50. 8.9.1 Roche Holding AG Company Information
  51. 8.9.2 Roche Holding AG Business Overview
  52. 8.9.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
  54. 8.9.5 Roche Holding AG Recent Developments
  55. 8.10 Owen Mumford
  56. 8.10.1 Owen Mumford Company Information
  57. 8.10.2 Owen Mumford Business Overview
  58. 8.10.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
  60. 8.10.5 Owen Mumford Recent Developments
  61. 8.11 Novo Nordisk
  62. 8.11.1 Novo Nordisk Company Information
  63. 8.11.2 Novo Nordisk Business Overview
  64. 8.11.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
  66. 8.11.5 Novo Nordisk Recent Developments
  67. 8.12 MannKind
  68. 8.12.1 MannKind Company Information
  69. 8.12.2 MannKind Business Overview
  70. 8.12.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
  72. 8.12.5 MannKind Recent Developments
  73. 8.13 Julphar
  74. 8.13.1 Julphar Company Information
  75. 8.13.2 Julphar Business Overview
  76. 8.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
  78. 8.13.5 Julphar Recent Developments
  79. 8.14 Insulet Corporation
  80. 8.14.1 Insulet Corporation Company Information
  81. 8.14.2 Insulet Corporation Business Overview
  82. 8.14.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
  84. 8.14.5 Insulet Corporation Recent Developments
  85. 8.15 Eli Lilly and Company
  86. 8.15.1 Eli Lilly and Company Company Information
  87. 8.15.2 Eli Lilly and Company Business Overview
  88. 8.15.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
  90. 8.15.5 Eli Lilly and Company Recent Developments
  91. 8.16 Debiotech
  92. 8.16.1 Debiotech Company Information
  93. 8.16.2 Debiotech Business Overview
  94. 8.16.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
  96. 8.16.5 Debiotech Recent Developments
  97. 8.17 Dance Biopharm
  98. 8.17.1 Dance Biopharm Company Information
  99. 8.17.2 Dance Biopharm Business Overview
  100. 8.17.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
  102. 8.17.5 Dance Biopharm Recent Developments
  103. 8.18 Copernicus
  104. 8.18.1 Copernicus Company Information
  105. 8.18.2 Copernicus Business Overview
  106. 8.18.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
  108. 8.18.5 Copernicus Recent Developments
  109. 8.19 Biocon
  110. 8.19.1 Biocon Company Information
  111. 8.19.2 Biocon Business Overview
  112. 8.19.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
  114. 8.19.5 Biocon Recent Developments
  115. 8.20 Beta Bionics
  116. 8.20.1 Beta Bionics Company Information
  117. 8.20.2 Beta Bionics Business Overview
  118. 8.20.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
  120. 8.20.5 Beta Bionics Recent Developments
  121. 8.21 BD
  122. 8.21.1 BD Company Information
  123. 8.21.2 BD Business Overview
  124. 8.21.3 BD Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 BD Home Insulin Delivery (Dosing) Devices Product Portfolio
  126. 8.21.5 BD Recent Developments
  127. 8.22 B. Braun
  128. 8.22.1 B. Braun Company Information
  129. 8.22.2 B. Braun Business Overview
  130. 8.22.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
  132. 8.22.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Home Insulin Delivery (Dosing) Devices Value Chain Analysis
  2. 9.1.1 Home Insulin Delivery (Dosing) Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Home Insulin Delivery (Dosing) Devices Sales Mode & Process
  6. 9.2 Home Insulin Delivery (Dosing) Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Home Insulin Delivery (Dosing) Devices Distributors
  9. 9.2.3 Home Insulin Delivery (Dosing) Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst